Cpwm, LLC Amgen Inc Transaction History

Cpwm, LLC

$1.06 Billion
Q3 2022

A detailed history of Cpwm, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cpwm, LLC holds 9,795 shares of AMGN stock, worth $2.59 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

9,795

Previous 10,581 7.43%

Holding current value

$2.59 Million

Previous $2.57 Million 14.22%

% of portfolio

0.21%

Previous 0.23%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $176,425 - $198,975	-786 Reduced 7.43%	9,795 $2.21 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $192,873 - $214,634	836 Added 8.58%	10,581 $2.57 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $409,815 - $453,363	1,869 Added 23.73%	9,745 $2.36 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $12,523 - $14,673	-59 Reduced 0.74%	7,876 $1.68 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $5,138 - $5,701	-22 Reduced 0.28%	7,935 $1.93 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $238,997 - $278,512	-1,077 Reduced 11.92%	7,957 $1.98 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $58,638 - $69,828	271 Added 3.09%	9,034 $2.08 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $7,978 - $8,872	34 Added 0.39%	8,763 $2.23 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $77,145 - $94,668	-390 Reduced 4.28%	8,729 $2.06 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $160,553 - $212,937	881 Added 10.69%	9,119 $1.85 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $51,465 - $66,150	272 Added 3.41%	8,238 $1.99 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $21,415 - $25,660	123 Added 1.57%	7,966 $1.54 Million
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $2,500 - $2,931	-15 Reduced 0.19%	7,843 $1.45 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $15,916 - $17,941	88 Added 1.13%	7,858 $1.49 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $35,144 - $41,025	197 Added 2.6%	7,770 $1.51 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $55,772 - $62,875	301 Added 4.14%	7,573 $1.57 Million
Q2 2018 Dec 21, 2018	SELL	$166.05 - $186.51 $237,451 - $266,709	-1,430 Reduced 16.43%	7,272 $1.34 Million
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $247,414 - $277,899	1,490 Added 20.66%	8,702 $1.61 Million
Q1 2018 Dec 21, 2018	BUY	$169.43 - $198.0 $298,705 - $349,074	1,763 Added 32.35%	7,212 $1.23 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $563,354 - $658,350	-3,325 Reduced 37.9%	5,449 $929,000
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $244,914 - $273,644	1,451 Added 19.81%	8,774 $1.53 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $186,026 - $212,392	-1,112 Reduced 13.18%	7,323 $1.37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	8,435	8,435 $1.45 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cpwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cpwm, LLC with notifications on news.

Account